SERB Pharmaceuticals participated in the 2026 Fall IDN Summit, engaging in discussions about Rare Oncology and Rare Emergency Medicine.

Public source

Publisher name

Public post

Thank you for connecting with us at the 2026 Fall IDN Summit! We truly appreciate the healthcare leaders and professionals who took the time to engage in meaningful disc…

Log in to read the full post

Company

SERB Pharmaceuticals

SERB is a fast-growing global speciality pharma company designed to address rare and urgent conditions.

Industry
Pharmaceutical Manufacturing
Location
Paris, FR
Company size
501–1,000 employees

About SERB Pharmaceuticals

Critical needs. Immediate action. SERB Pharmaceuticals exists for critical medical moments. We deliver life-saving medicines for rare and urgent conditions — when time, reliability, and execution make all the difference. By combining biotech agility with global pharma reliability, we operate end-to-end across 100+ countries, ensuring 70+ essential medicines reach patients and clinicians wherever and whenever they’re needed. Powered by purpose. Driven by passionate people who go the extra mile.

See more

Latest activity

10 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.